VSMRCT: Vaccine Social Media Randomized Intervention Trial

Sponsor
Kaiser Permanente (Other)
Overall Status
Completed
CT.gov ID
NCT01873040
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
1,675
1
3
39
42.9

Study Details

Study Description

Brief Summary

This study will assess the effectiveness of social media website devoted to vaccines to change immunization knowledge, perceptions and behavior. If effective, this intervention will represent an innovative, low cost and broadly applicable resource to reduce parental vaccination concerns.

The study has two hypothesis:
  1. Parents receiving usual care plus social media website will demonstrate higher early childhood immunization rates to parents receiving either usual plus non interactive website or usual care only.

  2. Parents receiving usual care plus social media website will demonstrate positive changes in knowledge, attitudes and beliefs supporting vaccination compared to parents receiving either usual care plus non-interactive website or usual care only.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Social Media plus information pages
  • Behavioral: Vaccine Information Pages
N/A

Detailed Description

Participants will be enrolled in the study, stratified based on hesitancy and randomly assigned to 1 of 3 study arms and followed for 1-2 years.

Study Design

Study Type:
Interventional
Actual Enrollment :
1675 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Randomized Intervention Trial to Evaluate a Vaccine Social Media Website
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Nov 1, 2016
Actual Study Completion Date :
Nov 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Social media plus information pages

Participants will have access to the vaccine social media website with information pages and social media features including discussion forums, blogs, chat with an expert, and ask an expert.

Behavioral: Social Media plus information pages
Participants will receive access to the study vaccine website information pages and social media feature including blogs, discussion forums, expert chats, and ask an expert.

Experimental: Information Pages

Participants will have website access to vaccine information pages.

Behavioral: Vaccine Information Pages
Participants will receive access to the study vaccine website information pages.

No Intervention: Usual Care

Participants will not have access to the vaccine website. They will receive pediatric care as usual.

Outcome Measures

Primary Outcome Measures

  1. Days under-immunized [2 years]

    Days under-immunized is a metric to identify immunization delay. For each vaccine dose calculate the difference between when the vaccine dose was actually administered and when the vaccine dose should have been administered according to the Advisory Committee on Immunization Practices (ACIP) schedule. That difference is summed across all doses and vaccines for a total number of days under-immunized for each child. Total days under immunized was calculated 200 days after life or after enrollment. If someone had 0 days at that time they were considered "up to date".

Secondary Outcome Measures

  1. Knowledge, Attitudes and Beliefs about immunizations [Baseline, Child age 3-5 months, Child age 12-15 months]

    Knowledge, attitudes, and beliefs will be measured with a survey at up to 3 time points during the study: 1) Initial enrollment in the study, 2) child's ag=4-6 months and 3) child's age=11-13 months.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women >20 weeks Pregnant (including parents of children up to 1 year of age).

  • 18 years of age

Exclusion Criteria:
  • Non english speak

  • Do not intend to use Kaiser insurance for the child

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaiser Permanente Colorado Institute for Health Research Denver Colorado United States 80231

Sponsors and Collaborators

  • Kaiser Permanente
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Jason M Glanz, PhD, Kaiser Permanente

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT01873040
Other Study ID Numbers:
  • 1R01HS021492-01
First Posted:
Jun 7, 2013
Last Update Posted:
Oct 18, 2017
Last Verified:
Oct 1, 2017
Keywords provided by Kaiser Permanente
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2017